Back to Journals » Cancer Management and Research » Volume 11

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

Total article views   HTML views PDF downloads Totals
11,087 Dovepress* 7,319+ 1,329 8,648
PubMed Central* 3,768 1,017 4,785
Totals 11,087 2,346 13,433
*Since 7 May 2019

View citations on PubMed Central and Google Scholar